When and How to Use Reversal Agents for Direct Oral Anticoagulants?

被引:0
|
作者
Antonio Gómez-Outes
Mª Luisa Suárez-Gea
Ramón Lecumberri
机构
[1] Agencia Española de Medicamentos y Productos Sanitarios (AEMPS),Division of Pharmacology and Clinical Drug Evaluation
[2] University Clinic of Navarra,Hematology Service
[3] Instituto de Salud Carlos III,Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV)
来源
关键词
Idarucizumab; Andexanet alfa; Prothrombin complex concentrates; Ciraparantag; VMX-C001; Anticoagulation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:371 / 380
页数:9
相关论文
共 50 条
  • [31] Direct Oral Anticoagulants: Quick Primer on When to Use and When to Avoid
    Bejjani, Antoine
    Bikdeli, Behnood
    THROMBOSIS AND HAEMOSTASIS, 2024,
  • [32] Reversal Agents in Development for the New Oral Anticoagulants
    Costin, James
    Ansell, Jack
    Laulicht, Bryan
    Bakhru, Sasha
    Steiner, Solomon
    POSTGRADUATE MEDICINE, 2014, 126 (07) : 19 - 24
  • [33] New Reversal Agents for Oral Anticoagulants on the Horizon
    Mazur, Marcus D.
    Sivakumar, Walavan
    Taussky, Philipp
    Park, Min S.
    WORLD NEUROSURGERY, 2015, 84 (06) : 1506 - 1507
  • [34] Direct oral anticoagulant reversal: how, when and issues faced
    Dzeshka, Mikhail S.
    Pastori, Daniele
    Lip, Gregory Y. H.
    EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (11) : 1005 - 1022
  • [35] Reversal of direct oral anticoagulants: a practical approach
    Shih, Andrew W.
    Crowther, Mark A.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 612 - 619
  • [36] THE REVERSAL OF DIRECT ORAL ANTICOAGULANTS IN ANIMAL MODELS
    Honickel, Markus
    Akman, Necib
    Grottke, Oliver
    SHOCK, 2017, 48 (02): : 144 - 158
  • [37] Meta-Analysis of Reversal Agents for Severe Bleeding Associated With Direct Oral Anticoagulants
    Gomez-Outes, Antonio
    Alcubilla, Pau
    Calvo-Rojas, Gonzalo
    Terleira-Fernandez, Ana Isabel
    Suarez-Gea, Luisa
    Lecumberri, Ramon
    Vargas-Castrillon, Emilio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (24) : 2987 - 3001
  • [38] How and when to measure anticoagulant effects of direct oral anticoagulants? Practical issues
    Tripodi, Armando
    Braham, Simon
    Scimeca, Barbara
    Moia, Marco
    Peyvandi, Flora
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2018, 128 (06): : 379 - 385
  • [39] Novel reversal agents and laboratory evaluation for direct-acting oral anticoagulants (DOAC): An update
    Shah, Shagun B.
    Pahade, Akhilesh
    Chawla, Rajiv
    INDIAN JOURNAL OF ANAESTHESIA, 2019, 63 (03) : 169 - 181
  • [40] CURRENT STRATEGIES FOR THE MANAGEMENT OF BLEEDING ASSOCIATED WITH DIRECT ORAL ANTICOAGULANTS AND A REVIEW OF INVESTIGATIONAL REVERSAL AGENTS
    Kaide, Colin G.
    Gulseth, Michael P.
    JOURNAL OF EMERGENCY MEDICINE, 2020, 58 (02): : 217 - 233